Roche announces FDA approval of one of the first HPV self-collection solutions in the U.S., expanding access and screening options to help eliminate cervical cancer
GlobeNewswire
· *More than half of all U.S. cervical cancer patients are underscreened*^*1**, which makes reducing barriers to sample collection..